Background
Methods
Data sources and study population
Statistical methods
Results
Monthly Visit (n = 1686) | Bimonthly Visit (n = 726) | Absolute Standardized Difference, % | P Value | |
---|---|---|---|---|
Demographics | ||||
Age | 66.5 ± 5.0 | 66.3 ± 5.2 | 4.2 | 0.35 |
Gender (female) | 812 (48.2) | 352 (48.5) | 0.6 | 0.88 |
BMI | 24.0 ± 3.6 | 23.4 ± 3.2 | 18.0 | < 0.001 |
Current smoker | 190 (11.3) | 77 (10.6) | 2.1 | 0.63 |
Regular exercise | 856 (51.0) | 363 (50.1) | 1.7 | 0.70 |
Daily alcohol intake | 350 (20.8) | 159 (22.0) | 2.9 | 0.23 |
Sleep well | 1496 (89.4) | 627 (86.7) | 8.3 | 0.06 |
Skip breakfast more than three times in a week | 49 (2.9) | 23 (3.2) | 1.5 | 0.73 |
Medication | ||||
Antihypertensive Drugs | 1094 (64.9) | 366 (50.4) | 29.6 | < 0.01 |
Oral Blood Glucose Lowering Drugs | 1359 (80.6) | 433 (59.6) | 39.9 | < 0.01 |
Lipid Lowering Drugs | 845 (50.1) | 291 (40.1) | 20.3 | < 0.01 |
Medical History | ||||
History of celebrovascular diseases | 87 (5.2) | 42 (5.8) | 2.8 | 0.53 |
History of heart diseases | 161 (9.5) | 89 (12.3) | 8.7 | 0.05 |
History of renal failure | 9 (0.5) | 1 (0.1) | 6.9 | 0.17 |
CKD | ||||
stage 1 | 232 (13.8) | 77 (10.6) | 9.7 | 0.03 |
stage 2 | 1165 (69.1) | 519 (71.5) | 5.2 | 0.24 |
stage 3 | 280 (16.6) | 127 (17.5) | 2.4 | 0.59 |
stage 4 | 7 (0.4) | 2 (0.3) | 2.4 | 0.61 |
stage 5 | 1 (0.1) | 1 (0.1) | 2.5 | 0.54 |
Systlic Blood Pressure (mmHg) | 130.9 ± 14.8 | 129.9 ± 15.9 | 6.7 | 0.13 |
Diastlic Blood Pressure (mmHg) | 74.4 ± 9.6 | 74.8 ± 9.7 | 3.5 | 0.43 |
HbA1c (%) | 6.2 ± 0.5 | 6.0 ± 0.5 | 31.3 | 0.00 |
LDL (mg/dl) | 116.2 ± 27.2 | 119.0 ± 28.7 | 10.2 | 0.02 |
HDL (mg/dl) | 58.5 ± 15.8 | 59.1 ± 14.9 | 3.9 | 0.38 |
TG (mg/dl) | 127.7 ± 71.9 | 122.8 ± 69.2 | 7.0 | 0.12 |
GOT (IU/L) | 25.0 ± 10.2 | 24.6 ± 9.4 | 3.9 | 0.39 |
GPT (IU/L) | 24.1 ± 13.7 | 23.3 ± 14.4 | 5.6 | 0.20 |
G-GTP (IU/L) | 38.8 ± 39.7 | 36.1 ± 37.2 | 7.1 | 0.11 |
Uric acid (mg/dl) | 5.5 ± 1.4 | 5.5 ± 1.3 | 2.8 | 0.53 |
eGFR (mL/min/1.73 m2) | 73.5 ± 15.3 | 72.2 ± 15.0 | 8.4 | 0.06 |
Albmin (g/dl) | 4.3 ± 0.2 | 4.3 ± 0.3 | 1.5 | 0.74 |
Hemoglobin (g/dl) | 13.8 ± 1.4 | 13.9 ± 1.4 | 11.4 | 0.01 |
Monthly Visit (n = 696) | Bimonthly Visit (n = 696) | Absolute Standardized Difference, % | P Value | |
---|---|---|---|---|
Demographics | ||||
Age | 66.3 ± 5.0 | 66.3 ± 5.1 | 0.3 | 0.95 |
Gender (female) | 329 (47.5) | 334 (48.2) | 1.4 | 0.79 |
BMI | 23.4 ± 3.0 | 23.4 ± 3.2 | 0.4 | 0.93 |
Current smoker | 63 (9.1) | 71 (10.3) | 3.7 | 0.47 |
Regular exercise | 334 (48.2) | 348 (50.2) | 4.0 | 0.45 |
Daily alcohol intake | 141 (20.4) | 150 (21.7) | 3.2 | 0.97 |
Sleep well | 595 (85.9) | 598 (86.3) | 1.3 | 0.82 |
Skip breakfast more than three times in a week | 20 (2.9) | 21 (3.0) | 0.8 | 0.87 |
Medication | ||||
Antihypertensive Drugs | 363 (52.4) | 344 (49.6) | 5.6 | 0.31 |
Oral Blood Glucose Lowering Drugs | 430 (62.0) | 414 (59.7) | 5.0 | 0.35 |
Lipid Lowering Drugs | 292 (42.1) | 281 (40.6) | 3.2 | 0.55 |
Medical History | ||||
History of celebrovascular diseases | 38 (5.5) | 40 (5.8) | 1.3 | 0.82 |
History of heart diseases | 92 (13.3) | 84 (12.1) | 3.7 | 0.52 |
History of renal failure | 0 (0.0) | 1 (0.1) | 2.5 | 0.32 |
CKD | ||||
stage 1 | 64 (9.2) | 70 (10.1) | 2.6 | 0.59 |
stage 2 | 492 (71.0) | 498 (71.9) | 1.9 | 0.72 |
stage 3 | 136 (19.6) | 122 (17.6) | 5.4 | 0.33 |
stage 4 | 1 (0.1) | 2 (0.3) | 2.5 | 0.56 |
stage 5 | 0 (0.0) | 1 (0.1) | 4.6 | 0.32 |
Systlic Blood Pressure (mmHg) | 129.6 ± 15.6 | 129.7 ± 15.9 | 1.0 | 0.86 |
Diastlic Blood Pressure (mmHg) | 74.8 ± 9.6 | 74.7 ± 9.8 | 0.9 | 0.87 |
HbA1c (%) | 6.0 ± 0.5 | 6.0 ± 0.5 | 2.6 | 0.71 |
LDL (mg/dl) | 118.0 ± 27.1 | 119.2 ± 28.8 | 4.5 | 0.40 |
HDL (mg/dl) | 59.3 ± 14.7 | 59.2 ± 15.0 | 0.3 | 0.95 |
TG (mg/dl) | 121.2 ± 66.8 | 123.2 ± 69.9 | 2.8 | 0.59 |
GOT (IU/L) | 24.2 ± 8.2 | 24.6 ± 9.4 | 4.3 | 0.37 |
GPT (IU/L) | 22.3 ± 11.5 | 23.3 ± 14.3 | 6.7 | 0.18 |
G-GTP (IU/L) | 34.4 ± 36.1 | 35.9 ± 37.5 | 4.1 | 0.43 |
Uric acid (mg/dl) | 5.5 ± 1.3 | 5.5 ± 1.3 | 0.8 | 0.88 |
eGFR (mL/min/1.73 m2) | 71.6 ± 13.6 | 72.1 ± 14.9 | 2.9 | 0.57 |
Albmin (g/dl) | 4.3 ± 0.3 | 4.3 ± 0.3 | 0.8 | 0.88 |
Hemoglobin (g/dl) | 14.0 ± 1.3 | 14.0 ± 1.4 | 0.7 | 0.89 |
Monthly follow-up (n = 693) | Bimonthly follow-up (n = 693) | ||||
---|---|---|---|---|---|
Baseline, mean ± SD or n (%) | Next year, mean ± SD or n (%) | Baseline, mean ± SD or n (%) | Next year, mean ± SD or n (%) | Bionthly - monthly difference (95% CI)a | |
HbA1c (%) | 6.0 ± 0.5 | 6.1 ± 0.6 | 6.0 ± 0.5 | 6.1 ± 0.5 | −0.02 (−0.07 to 0.03) |
Systolic blood pressure (mmHg) | 129.6 ± 15.6 | 129.4 ± 14.7 | 129.7 ± 15.9 | 129.8 ± 15.3 | 0.26 (−1.32 to 1.83) |
Diastolic blood pressure (mmHg) | 74.8 ± 9.6 | 74.4 ± 9.4 | 74.7 ± 9.8 | 74.4 ± 9.4 | 0.11 (− 0.87 to 1.09) |
LDL (mg/dl) | 118.0 ± 27.1 | 115.9 ± 25.5 | 119.2 ± 28.8 | 116.5 ± 26.8 | −0.61 (−3.06 to 1.83) |
HDL (mg/dl) | 59.3 ± 14.7 | 59.7 ± 15.2 | 59.2 ± 15.0 | 59.6 ± 15.3 | 0.01 (−0.79 to 0.81) |
TG (mg/dl) | 121.2 ± 66.8 | 125.9 ± 77.1 | 123.2 ± 69.9 | 124.3 ± 67.8 | −3.6 (−10.28 to 3.08) |
BMI | 23.4 ± 3.0 | 23.4 ± 3.0 | 23.4 ± 3.2 | 23.4 ± 3.2 | −0.06 (−0.13 to 0.02) |
Current smoker (%) | 63 (9.1) | 65 (9.4) | 71 (10.3) | 70 (10.1) | −0.43 (−2.11 to 1.24) |
Regular exercise (%) | 334 (48.2) | 356 (51.5) | 348 (50.2) | 365 (52.8) | −0.73 (−5.46 to 4.00)b |
Sleep well (%) | 595 (85.9) | 588 (85.3) | 598 (86.3) | 590 (85.5) | −0.43 (−4.16 to 3.29) |
Daily alcohol intake (%) | 141 (20.4) | 142 (20.5) | 150 (21.7) | 149 (21.5) | −0.29 (−2.45 to 1.87) |
Annual cost (JPY) | 161,294 ± 151,826 | 96,292 ± 179,272 | − 6500.17 (− 8253.53 to − 4746.80)§ |